What is Glutathione?
Glutathione (GSH) is an endogenous tripeptide and the cell's most important antioxidant. It neutralizes free radicals, is central to liver detoxification and keeps other antioxidants active. In the scene it is often used for skin, detox and general wellbeing.
Comparison
Glutathione and related entries
Lexicon entries that contain glutathione or are used in a similar way. Tap a card to open its entry.
Simplified: similar use does not mean the same effect. There are no robust comparison studies.
How it works
Glutathione scavenges reactive oxygen species and is a cofactor for detoxification enzymes. It also regenerates vitamins C and E. Under oxidative stress GSH levels fall. Topping them up is meant to relieve cells.
Where it acts
Where glutathione was studied
Tap a point or a card. Glutathione does not act through a receptor, shown are findings from studies.
- Blood
Stores in red blood cells 29 to 35% higher after 6 months by mouth2
Observed in trials - Brain
Parkinson's disease: nasal spray no better than placebo after three months6
Observed in trials - Skin
Melanin index tended to be lower than with placebo, women over 12 weeks, by mouth7
Observed in trials
What you need
Supplies
2 things, numbered as in the picture
Tick off what you already have. Vial and BAC water are our real shop photos at the same size.
-
Glutathione vial
The glutathione vial (lyophilized powder).
-
BAC water, syringes and swabs
Bacteriostatic water, U-100 insulin syringes, alcohol swabs.
As an Amazon associate we earn from qualifying purchases. Links open Amazon - no extra cost for you.
Reconstitution
Use the peptide calculator. A 600mg vial with 3ml water gives 200mg per ml. Do not aim for much more than about 200mg per ml, glutathione only dissolves in water up to just under 300mg per ml: a 1200mg vial therefore needs 6ml and a 1500mg vial 7.5ml, i.e. more than one BAC vial. Just add the water to the vial and let it dissolve.
Step by step
Dissolving the powder
Four steps, the same for every vial size.
- 1Wipe the cap
Clean the rubber stopper with an alcohol swab.
- 2Add BAC water
Just add it, it does not matter if it hits the powder directly.
- 3Swirl or shake
Until everything has dissolved, both are fine.
- 4Draw up
With the U-100 insulin syringe.
Dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
Injection
The injection is subcutaneous, into the fat layer under the skin. Common spots are the abdomen (keep about two finger-widths clear of the navel), the front and the inner side of the thigh, or the back of the upper arm.
The short version:
Injection
Where and at what angle
Pick a spot or switch the angle. Subcutaneous means: into the fat layer, not the muscle.
Rotate the spot each time, never the same one twice in a row.
Rule of thumb: where there is more fat under the skin, insert straight at 90 degrees. In lean people with little fat, 45 degrees, so the needle stays in the fat layer. Simplified diagram.
-
Clean the spot with an alcohol swab and let it dry
-
Pinch up a small fold of skin
-
Insert the needle: at 90 degrees where there is more fat under the skin, at 45 degrees in lean people with little fat
-
Inject slowly, wait a moment, then withdraw
-
Put the needle straight into the sharps container
Rotate the site each time so the tissue does not get irritated. Never the same spot twice in a row.
What the research shows
Glutathione itself is well understood. A clean study (Richie, 2015) showed that oral administration over months measurably raised the body's own glutathione stores. For injectable use and the cosmetic promises (skin lightening) the data is thinner, so stay honest here.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Glutathione stores after 6 months2
Rise from baseline, 54 healthy adults, daily by mouth
With the higher dose red blood cells, plasma and lymphocytes rose by 30 to 35%. One month after stopping the levels were back at baseline.
Symptoms of nerve damage during chemotherapy10
Mean in points on a scale of 0 to 100, higher = fewer symptoms, phase 3 trial
No significant difference. The time to more severe nerve damage even slightly favoured placebo. The authors do not support glutathione for this purpose.
Research status
Where the research stands
Shown are trials with glutathione itself, as an infusion, nasal spray, inhalation, capsule or on the skin. Trials with precursors such as N-acetylcysteine are left out. As of 26 Oct 2026. 11
- Preclinical Cell and animal studies on oxidative stress and detoxification
- Phase 1 6 trials, 5 completed
- Phase 2 5 trials, 4 completed
- Phase 3 3 trials, 2 completed
- Approval not yet
Show all 9 phase 2, 3 and 4 trials on a timelineHide timeline
NCT01177319 · 20 participants, started Sept 2003, primary endpoint reached Mar 2007.
Registry entry ↗ · Results not yet in PubMed
NCT00506688 · 153 participants, started Jul 2007, primary endpoint reached May 2010.
Registry entry ↗ · Results not yet in PubMed
NCT02424708 · 45 participants, started Apr 2015, primary endpoint reached Mar 2016.
Registry entry ↗ · Results: Mischley et al., Journal of Parkinson's Disease, 2017
NCT03020719 · 60 participants, started Jun 2017, primary endpoint reached Dec 2018.
Registry entry ↗ · Results not yet in PubMed
NCT06620523 · 242 participants (planned), started Jul 2024, primary endpoint planned Jun 2027. Tests several agents.
N08CA · NCT02311907 · 195 participants, started Dec 2009, primary endpoint reached Aug 2012.
Registry entry ↗ · Results: Leal et al., Cancer, 2014, ClinicalTrials.gov, NCT02311907 (Ergebnisse eingetragen)
NCT02125045 · 16 participants, started Feb 2014, primary endpoint reached May 2014.
Registry entry ↗ · Results not yet in PubMed
NCT07475546 · 30 participants (planned), started Jul 2025, primary endpoint planned Apr 2026. Tests several agents.
NCT05954052 · 6 participants, started Jul 2019, stopped early Aug 2023.
Bar: start to primary endpoint (planned for running trials). Green = completed, blue = progress until 26 Oct 2026, grey = stopped early. Phase 1: 6 trials on safety and pharmacokinetics, not shown as bars.
On the skin
Glutathione has also been tested as a lotion, in its oxidised form (GSSG). In a placebo-controlled study with 30 women the glutathione lotion went on one half of the face for ten weeks and a lotion without active ingredient on the other. On the glutathione side the melanin value fell more and the skin became moister and smoother, with no notable side effects (Watanabe 2014). The study was run by a glutathione manufacturer.
Side effects
- Generally well tolerated, mainly local reactions.
- With very high or fast IV doses, circulatory reactions are possible.
Tolerability
Serious adverse events in the phase 3 trial
Patients on chemotherapy, infusion before each dose.
| Event | Placebo | Glutathione infusion |
|---|---|---|
| Serious adverse events10 | 1% | 7% |
Figures from the registry record. The authors found no difference in apparent toxicities. In a small nasal spray study in Parkinson's disease one participant on the higher dose developed cardiomyopathy.1046
Storage
Before mixing the powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. After mixing, keep in the fridge (2 to 8 degrees), do not freeze. It stays good there for at least 4 to 6 months with barely any loss of potency, in practice considerably longer. Swirl or shake to mix, both are fine.
Shelf life
How long it keeps
Robust, no fridge needed. Best kept in the dark.
At least 4 to 6 months with barely any loss of potency.
- Keep it dark
- Dissolved: 2 to 8 degrees
- Note the mixing date on the vial